FDA Requires Additional Data For Seroquel XR Supplemental New Drug Application (Medical News Today)
The U.S. FDA (Food and Drug Administration) has asked AstraZeneca, the makers of Seroquel XR (quetiapine fumarate), for additional information for its extended release tablets for the treatment of MDD (Major Depressive Disorder) in adult patients. The FDA's CRL (Complete Response Letter) was sent to AstraZeneca on 24th December.

Treadmill Desks: A Healthy Alternative on the Heels of FDA Warnings of 25 Weight Loss Products (PRWeb)
25 diet products have received stern consumer warnings from the FDA for potential dangers yet a simpler, safer, more effective solution exists. (PRWeb Dec 24, 2008) Read the full story at http://www.prweb.com/releases/Treadmill_Desk/Trek_Desk/prweb1792264.htm

FDA Seeks Recall Of 25 Weight Loss Pills With Potentially Unsafe Ingredients (Medical News Today)
The Food and Drug Administration (FDA) in the United States is seeking to recall 23 different products marketed as for weight loss because they contain undeclared active pharmaceutical substances that may pose serious health risks to consumers. The products are marketed over the Internet and in retail stores, and in some cases are described as "dietary supplements" .